Perioperative Modification of Hemostasis During Ventricular Assist Device Implantation (HemostVAD)
Sponsor: University Hospital, Strasbourg, France
Terminated
Due to inclusion difficulties following the evolution of surgical indications, which were clearly restricted, making patient inclusion too complex.
Other terminated trials from University Hospital, Strasbourg, France
- Healthy Control Subjects · Apr 2025
- Cystic Fibrosis-related Diabetes · Phase PHASE4 · Jan 2025
- Kidney Transplant Recipients · Nov 2024
- Diagnosed With Uretral Fibroscopy · Sep 2024
- Patients with Colorectal Cancer · Phase NA · Sep 2024
See all terminations from University Hospital, Strasbourg, France
A observational or N/A phase clinical study on End-stage Heart Failure, this trial is terminated or withdrawn. The trial is conducted by University Hospital, Strasbourg, France and has accumulated 10 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Apr 2025 — Present [monthly]
Terminated
-
Nov 2024 — Apr 2025 [monthly]
Terminated
Status: Unknown → Terminated
-
Sep 2024 — Nov 2024 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Sep 2022 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
May 2020 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — May 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Strasbourg, France
For direct contact, visit the study record on ClinicalTrials.gov .